Literature DB >> 18752820

Enhanced expression of murine beta-defensins (MBD-1, -2,- 3, and -4) in upper and lower airway mucosa of influenza virus infected mice.

Kong T Chong1, Rajagowthamee R Thangavel, Xuehui Tang.   

Abstract

Although defensins are known to inhibit the replication of human influenza A virus (IAV) in vitro, their in vivo expression during IAV infection is not known. Here we investigated mRNA and protein expression of several beta-defensins in the airways of IAV infected mice. Expression of murine beta-defensin (MBD)-3 and -4 was enhanced (3 to 5-fold, p<0.01) in infected lungs, trachea and sinonasal mucosa. MBD-3 and -4 expressions were correlated with the time course of acute IAV infection suggesting their induction by IAV infection. Infected mice also showed increased levels of surfactant protein-D especially in the sinonasal mucosa. MBD-3 and -4 were localized to the conducting airway epithelial cells but not the alveolar tissue. We conclude that IAV infection upregulated the expression of inducible beta-defensins in both the upper and lower airways. These novel findings suggest that beta-defensins might contribute to innate and adaptive immune responses targeted against IAV infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18752820     DOI: 10.1016/j.virol.2008.07.024

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

Review 1.  How the Respiratory Epithelium Senses and Reacts to Influenza Virus.

Authors:  Kambez H Benam; Laura Denney; Ling-Pei Ho
Journal:  Am J Respir Cell Mol Biol       Date:  2019-03       Impact factor: 6.914

Review 2.  Defensins in viral infections.

Authors:  Jian Ding; Yi-Ying Chou; Theresa L Chang
Journal:  J Innate Immun       Date:  2009-06-24       Impact factor: 7.349

3.  Antimicrobial peptides alter early immune response to influenza A virus infection in C57BL/6 mice.

Authors:  Kim S LeMessurier; Yanyan Lin; Jonathan A McCullers; Amali E Samarasinghe
Journal:  Antiviral Res       Date:  2016-08-13       Impact factor: 5.970

4.  Modulation of human beta-defensin-1 (hBD-1) in plasmacytoid dendritic cells (PDC), monocytes, and epithelial cells by influenza virus, Herpes simplex virus, and Sendai virus and its possible role in innate immunity.

Authors:  Lisa K Ryan; Jihong Dai; Zhiwei Yin; Nicholas Megjugorac; Victoria Uhlhorn; Sunghan Yim; Kyell D Schwartz; Joshua M Abrahams; Gill Diamond; Patricia Fitzgerald-Bocarsly
Journal:  J Leukoc Biol       Date:  2011-05-06       Impact factor: 4.962

5.  The chromosomal protein HMGN2 mediates the LPS-induced expression of β-defensins in mice.

Authors:  Lu-Xia Deng; Gui-Xia Wu; Yue Cao; Bo Fan; Xiang Gao; Xiao-Hai Tang; Ning Huang
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

Review 6.  Damage-associated molecular patterns and their receptors in upper airway pathologies.

Authors:  Koen Van Crombruggen; Fenila Jacob; Nan Zhang; Claus Bachert
Journal:  Cell Mol Life Sci       Date:  2013-05-15       Impact factor: 9.261

7.  The role of innate immunity in the pathogenesis of chronic rhinosinusitis.

Authors:  Andrew P Lane
Journal:  Curr Allergy Asthma Rep       Date:  2009-05       Impact factor: 4.806

8.  Chronic exercise reduces illness severity, decreases viral load, and results in greater anti-inflammatory effects than acute exercise during influenza infection.

Authors:  Young-Je Sim; Shan Yu; Kyoung-Jin Yoon; Kyoungjin J Yoon; Christie M Loiacono; Marian L Kohut
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

9.  Specific binding and chemotactic activity of mBD4 and its functional orthologue hBD2 to CCR6-expressing cells.

Authors:  Johann Röhrl; De Yang; Joost J Oppenheim; Thomas Hehlgans
Journal:  J Biol Chem       Date:  2010-01-12       Impact factor: 5.157

10.  Integrating "omics" Technologies to Conceptualize Dynamic Antimicrobial Peptide Responses.

Authors:  Jennifer K Plichta; Vanessa Nienhouse; Katherine A Radek
Journal:  Front Immunol       Date:  2012-09-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.